Novaccess Global Stock Today
| XSNX Stock | USD 0.01 0 80.00% |
Performance8 of 100
| Odds Of DistressLess than 37
|
NovAccess Global is trading at 0.009 as of the 3rd of December 2024; that is 80.00 percent increase since the beginning of the trading day. The stock's open price was 0.005. NovAccess Global has about a 37 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for NovAccess Global are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2023 and ending today, the 3rd of December 2024. Click here to learn more.
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio. Novaccess Global operates under Biotechnology classification in the United States and is traded on OTC Exchange. The company has 19.57 M outstanding shares. More on NovAccess Global
Moving against NovAccess Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
NovAccess Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
NovAccess Global [XSNX] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.11 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NovAccess Global's market, we take the total number of its shares issued and multiply it by NovAccess Global's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. NovAccess Global conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 19.57 M outstanding shares.
NovAccess Global currently holds about 89.94 K in cash with (903.49 K) of positive cash flow from operations.
Check NovAccess Global Probability Of Bankruptcy
Ownership AllocationNovAccess Global maintains a total of 19.57 Million outstanding shares. NovAccess Global holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check NovAccess Ownership Details
NovAccess Global Risk Profiles
| Mean Deviation | 14.74 | |||
| Semi Deviation | 13.93 | |||
| Standard Deviation | 28.14 | |||
| Variance | 791.95 |
NovAccess Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in NovAccess Global without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Additional Tools for NovAccess Pink Sheet Analysis
When running NovAccess Global's price analysis, check to measure NovAccess Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovAccess Global is operating at the current time. Most of NovAccess Global's value examination focuses on studying past and present price action to predict the probability of NovAccess Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovAccess Global's price. Additionally, you may evaluate how the addition of NovAccess Global to your portfolios can decrease your overall portfolio volatility.